IMPLICATION of FAST-TRACK PROTOCOL for HIP FRACTURE FIXATION in ALEXANDRIA UNIVERSITY HOSPITALS
Launched by ALEXANDRIA UNIVERSITY · Mar 9, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
One hundred and fifty adult patients of American Society of Anesthesiologists (ASA) physical status I, II or III, age ≥ 50 years will be admitted to the department of orthopaedics surgery and traumatology, El Hadara University Hospital and scheduled for internal fixation under either spinal or general anaesthesia starting from January 2025. Patients will be divided into two groups: Group Fast pathway: Seventy-five patients treated according to fast-track protocol. Group Conventional pathway: Seventy-five patients who failed to be included in the fast track protocol will be included in the c...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥ 50 years.
- • 2. ASA physical status class I, II or III.
- Exclusion Criteria:
- • 1. Poly-trauma patients.
- • 2. Patients with history of sensitivity to the studied drugs.
- • 3. Psychiatric disease or seizure disorder requiring medication within the previous 2 years.
- • 4. Opioid tolerant patients.
- • 5. Patients with preoperative cognitive dysfunction.
Trial Officials
Moustafa Abdelaziz Ahmed, MD
Study Director
Alexandria University
Maher Doghiem, MD
Study Director
Alexandria University
Ahmed Shehab, MD
Study Director
Alexandria University
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, Egypt, Alexandria, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported